B.Kevin Park

1.8k total citations
30 papers, 1.4k citations indexed

About

B.Kevin Park is a scholar working on Pharmacology, Biochemistry and Pharmacology. According to data from OpenAlex, B.Kevin Park has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 9 papers in Biochemistry and 6 papers in Pharmacology. Recurrent topics in B.Kevin Park's work include Pharmacogenetics and Drug Metabolism (12 papers), Malaria Research and Control (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). B.Kevin Park is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Malaria Research and Control (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). B.Kevin Park collaborates with scholars based in United Kingdom, United States and Canada. B.Kevin Park's co-authors include Munir Pirmohamed, Neil R. Kitteringham, Stephen A. Ward, Alasdair Breckenridge, John H.K. Yeung, Dominic P. Williams, Stephen F. Madden, Dean J. Naisbitt, Patrick G. Bray and William F. Pool and has published in prestigious journals such as Trends in Pharmacological Sciences, Tetrahedron and Biochemical Pharmacology.

In The Last Decade

B.Kevin Park

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.Kevin Park United Kingdom 21 461 282 274 235 202 30 1.4k
B.K. Park United Kingdom 20 557 1.2× 224 0.8× 239 0.9× 86 0.4× 213 1.1× 57 1.3k
B. K. Park United Kingdom 21 646 1.4× 340 1.2× 259 0.9× 60 0.3× 275 1.4× 39 1.6k
Michael H. Tarbit United Kingdom 27 931 2.0× 230 0.8× 457 1.7× 156 0.7× 434 2.1× 43 2.3k
Matthew Wright United States 25 284 0.6× 212 0.8× 472 1.7× 342 1.5× 352 1.7× 85 1.8k
Shangara S. Dehal United States 19 584 1.3× 149 0.5× 418 1.5× 69 0.3× 275 1.4× 27 1.5k
Kevin B. Alton United States 26 501 1.1× 272 1.0× 691 2.5× 214 0.9× 545 2.7× 49 2.8k
Toshiro Niwa Japan 27 1.1k 2.3× 258 0.9× 452 1.6× 134 0.6× 505 2.5× 98 2.2k
B. Kevin Park United Kingdom 25 803 1.7× 492 1.7× 751 2.7× 373 1.6× 303 1.5× 41 2.6k
Mitchell N. Cayen China 21 349 0.8× 239 0.8× 473 1.7× 112 0.5× 221 1.1× 77 1.6k
Lesley A. Stanley United Kingdom 23 452 1.0× 110 0.4× 723 2.6× 151 0.6× 367 1.8× 41 1.7k

Countries citing papers authored by B.Kevin Park

Since Specialization
Citations

This map shows the geographic impact of B.Kevin Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.Kevin Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.Kevin Park more than expected).

Fields of papers citing papers by B.Kevin Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.Kevin Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.Kevin Park. The network helps show where B.Kevin Park may publish in the future.

Co-authorship network of co-authors of B.Kevin Park

This figure shows the co-authorship network connecting the top 25 collaborators of B.Kevin Park. A scholar is included among the top collaborators of B.Kevin Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.Kevin Park. B.Kevin Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Dominic P. & B.Kevin Park. (2003). Idiosyncratic toxicity: the role of toxicophores and bioactivation. Drug Discovery Today. 8(22). 1044–1050. 65 indexed citations
2.
Pirmohamed, Munir, et al.. (2002). The danger hypothesis—potential role in idiosyncratic drug reactions. Toxicology. 181-182. 55–63. 119 indexed citations
4.
Pirmohamed, Munir & B.Kevin Park. (2001). Genetic susceptibility to adverse drug reactions. Trends in Pharmacological Sciences. 22(6). 298–305. 215 indexed citations
5.
Park, B.Kevin, Neil R. Kitteringham, Helen Powell, & Munir Pirmohamed. (2000). Advances in molecular toxicology–towards understanding idiosyncratic drug toxicity. Toxicology. 153(1-3). 39–60. 88 indexed citations
6.
Ratra, Gurpreet S., et al.. (2000). Methapyrilene hepatotoxicity is associated with increased hepatic glutathione, the formation of glucuronide conjugates, and enterohepatic recirculation. Chemico-Biological Interactions. 129(3). 279–295. 22 indexed citations
7.
Wilson, A. S., Dominic P. Williams, Carl D. Davis, Malcolm D. Tingle, & B.Kevin Park. (1997). Bioactivation and inactivation of aflatoxin B1 by human, mouse and rat liver preparations: Effect on SCE in human mononuclear leucocytes. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 373(2). 257–264. 13 indexed citations
8.
Hawley, Shaun R., Patrick G. Bray, B.Kevin Park, & Stephen A. Ward. (1996). Amodiaquine accumulation in Plasmodium falciparum as a possible explanation for its superior antimalarial activity over chloroquine. Molecular and Biochemical Parasitology. 80(1). 15–25. 66 indexed citations
9.
Pirmohamed, Munir, Neil R. Kitteringham, Andrea Gaedigk, et al.. (1995). Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. Biochemical Pharmacology. 50(9). 1353–1359. 64 indexed citations
10.
O’Neill, Paul M., et al.. (1995). Quinoline analogues of ortho-quinodimethane. Tetrahedron Letters. 36(33). 5983–5986. 13 indexed citations
11.
Tingle, Malcolm D., Munir Pirmohamed, A. S. Wilson, et al.. (1993). An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes. Biochemical Pharmacology. 46(9). 1529–1538. 66 indexed citations
12.
Madden, Stephen F., Thomas F. Woolf, William F. Pool, & B.Kevin Park. (1993). An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Biochemical Pharmacology. 46(1). 13–20. 88 indexed citations
13.
Pirmohamed, Munir, Neil R. Kitteringham, Alasdair Breckenridge, & B.Kevin Park. (1992). The effect of enzyme induction on the cytochrome P450-mediated bioactivation of carbamazepine by mouse liver microsomes. Biochemical Pharmacology. 44(12). 2307–2314. 45 indexed citations
14.
Page, Philip C. Bulman, Andrew E. Graham, & B.Kevin Park. (1992). A convenient preparation of symmetrical and unsymmetrical 1,2-diketones: application to fluorinated phenytoin synthesis. Tetrahedron. 48(35). 7265–7274. 21 indexed citations
15.
Yeung, John H.K. & B.Kevin Park. (1989). Effect of inhibition of glutathione synthesis on the metabolism and protein conjugation of [14C]captopril in the rat. Biochemical Pharmacology. 38(7). 1188–1192. 4 indexed citations
16.
Cholerton, S. & B.Kevin Park. (1986). Quantitative analysis of pharmacological concentrations of vitamin K1 and vitamin K1 2,3-epoxide in rat liver by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 375. 147–153. 6 indexed citations
17.
Yeung, John H.K., John W. Coleman, & B.Kevin Park. (1985). Drug-protein conjugates—IX. Biochemical Pharmacology. 34(22). 4005–4012. 32 indexed citations
18.
Yeung, John H.K., Alasdair Breckenridge, & B.Kevin Park. (1983). Drug protein conjugates—VI. Role of glutathione in the metabolism of captopril and captopril plasma protein conjugates. Biochemical Pharmacology. 32(23). 3619–3625. 23 indexed citations
19.
Maggs, James L., Peter Grabowski, & B.Kevin Park. (1983). Protection of catechol oestrogen from oxidation during enzymic hydrolysis of biliary conjugates. Journal of Steroid Biochemistry. 19(2). 1235–1237. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026